FDA Plays

[ToysInTheAttic]

DCTH the energizer bunny...

Delcath Systems (DCTH) option prices elevated into data
8:50 am ET 04/09/2010 - StreetInsider
Delcath Systems (Nasdaq: DCTH) is recently up 15c to $9.62 in pre-open trading. DCTH is expected to release in early April late-stage data from its recently completed Phase three trial of melphalan using the PHP System (Percutaneous Hepatic Perfusion), technology that allows physicians to deliver higher doses of existing chemotherapy drugs to the liver without exposing the entire patient's body to the anti-cancer drugs. Key secondary data as survivability will likely not be presented at this time. April 10 straddle is priced at $2.45, May 10 is at $4.50, and June 10 is at $5.20 according to Track Data suggesting large price movement.